Prof. Dr. med. Christian Meier

Baumann, Sandra, Sewing, Lilian, Traechslin, Cyril, Verhagen-Kamerbeek, Wilma, Grize, Leticia, Kraenzlin, Marius, & Meier, Christian. (2025). Serum Pentosidine in Relation to Obesity in Patients with Type 2 Diabetes and Healthy Controls [Journal-article]. Calcified Tissue International, 116(1). https://doi.org/10.1007/s00223-024-01338-6

Thierry, Susanne, Peterson, Caspar Joyce, Pfammatter, Stéphanie, Tardio, Patricia Arroyo, Meier, Christian, Delko, Tarik, Iten, Vasco, Zuern, Christine S., Kühne, Michael, Epstein, Michael, Othman, Alaa, Zamboni, Nicola, Reinisch, Isabel, Ghosh, Adhideb, Wolfrum, Christian, & Seelig, Eleonora. (2025). Short-term Metformin Protects Against Glucocorticoid-Induced Toxicity in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial [Journal-article]. Diabetes Care, 48(5), 719–727. https://doi.org/10.2337/dc24-2039

Meier, Christian, Eastell, Richard, Pierroz, Dominique D, Lane, Nancy E, Al-Daghri, Nasser, Suzuki, Atsushi, Napoli, Nicola, Mithal, Ambrish, Chakhtoura, Marlene, Fuleihan, Ghada El-Hajj, & Ferrari, Serge. (2023). Biochemical Markers of Bone Fragility in Patients With Diabetes [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 108(10), e923–e936. https://doi.org/10.1210/clinem/dgad255

Monnerat, Sophie, Refardt, Julie, Potasso, Laura, Meier, Christian, & Christ-Crain, Mirjam. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238

Ferrari, Serge, & Meier, Christian. (2023). Reply to comment by Suhm N on: Ferrari S, et al. 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Medical Weekly, 153(4). https://doi.org/10.57187/smw.2023.40075

Jung, Ruedi, Zürcher, Simeon J., Schindera, Christina, Eser, Prisca, Meier, Christian, Schai, Anna, Braun, Julia, Deng, Wei Hai, Hebestreit, Helge, Neuhaus, Cornelia, Schaeff, Jonathan, Rueegg, Corina S., von der Weid, Nicolas X., & Kriemler, Susi. (2023). Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit). International Journal of Cancer, 152(2), 162–171. https://doi.org/10.1002/ijc.34234

De Geyter, C., Matt, L., De Geyter, I., Moffat, R., & Meier, C. (2023). In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable. Human Reproduction Open, 2023(4). https://doi.org/10.1093/hropen/hoad038

R Charlier SH, Meier C, Jick SS, Meier CR, & Becker C. (2022). Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case–control study. Cardiovascular Diabetology, 21(1), 2. https://doi.org/10.1186/s12933-021-01432-1

Bischof E, Schwab FD, Georgescu Margarint EL, Montavon C, Zünti I, Schollbach A, Schötzau A, Hirschmann A, Landin J, Meier C, Christian K, & Vetter M. (2022). Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience. Bone Reports, 16, 101160. https://doi.org/10.1016/j.bonr.2021.101160

Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, & Meier C. (2022). Bone Microarchitecture and Strength in Long-Standing Type 1 Diabetes. Journal of Bone and Mineral Research, 37(5), 837–847. https://doi.org/10.1002/jbmr.4517

Jehle‐kunz, Sigrid, Häuselmann, Hans-Jörg, Keschawarzi, Mitra, Lamy, Olivier, Luzuy, Franck, Marcoli, Natalie, Meier, Christian, Uebelhart, Brigitte, & Wiedersheim, Peter. (2022). Risk Factors, Manifestation, and Awareness of Osteoporosis among Patients of Various Specialists in Switzerland: Results of a National Survey. Healthcare (Switzerland), 10(2). https://doi.org/10.3390/healthcare10020295

Paccou J., Tsourdi E., Meier C., Palermo A., Pepe J., Body J.-J., & Zillikens M.C. (2022). Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS). Bone, 154. https://doi.org/10.1016/j.bone.2021.116236

Potasso L, Potasso L, Refardt J., Meier C, & Christ-Crain M. (2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD. European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604

Vavanikunnel, J., Sewing, L., Triantafyllidou, M., Steighardt, A., Baumann, S., Egger, A., Grize, L., Felix, B., Kraenzlin, M., Henzen, C., & Meier, C. (2022). Determinants of low bone turnover in type 2 diabetes-the role of PTH. Calcif Tissue Int, 111(6), 587–596. https://doi.org/10.1007/s00223-022-01022-7

Charlier, Sarah, Vavanikunnel, Janina, Becker, Claudia, Jick, Susan S., Meier, Christian, & Meier, Christoph R. (2021). Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study. Journal of Clinical Endocrinology and Metabolism, 106(2), 554–566. https://doi.org/10.1210/clinem/dgaa796

Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, & Langdahl B. (2021). Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS. Journal of Clinical Endocrinology and Metabolism, 106(1), 264–281. https://doi.org/10.1210/clinem/dgaa756

Zürcher SJ, Jung R, Monnerat S, Schindera C, Eser P, Meier C, Rueegg CS, von der Weid NX, & Kriemler S. (2020). High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit. International Journal of Cancer, 147(7), 1845–1854. https://doi.org/10.1002/ijc.32963

Ferrari S, Lippuner K, Lamy O, & Meier C. (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss Medical Weekly, 150(3940), w20352. https://doi.org/10.4414/smw.2020.20352

Pepe J., Body J.-J., Hadji P., McCloskey E., Meier C., Obermayer-Pietsch B., Palermo A., Tsourdi E., Zillikens M.C., Langdahl B., & Ferrari S. (2020). Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF. Journal of Clinical Endocrinology and Metabolism, 105(8), 2487–2506. https://doi.org/10.1210/clinem/dgaa306

Müller, Fabio, Appelt, Konrad A., Meier, Christian, & Suhm, Norbert. (2020). Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee. Knee Surgery Sports Traumatology Arthroscopy, 28, 408–417. https://doi.org/10.1007/s00167-019-05598-w

Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, Meier C, McCloskey EV, Pepe J, & Zillikens MC. (2019). Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society. Bone, 127, 401–418. https://doi.org/10.1016/j.bone.2019.07.006

Biver E, Calmy A, & Meier C. (2019). Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf (Patent No. 8). Osteoporosis International, 30(8), Article 8. https://doi.org/10.1007/s00198-019-05025-3

Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, & Meier C. (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporosis International, 30(5), 1125–1135. https://doi.org/10.1007/s00198-018-4794-0

Struja T, Jutzi R, Imahorn N, Kaeslin M, Boesiger F, Kutz A, Mundwiler E, Huber A, Kraenzlin M, Mueller B, Meier C, Bernasconi L, & Schuetz P. (2019). Comparison of Five TSH-receptor antibody assays in Graves’ disease: Results from an observational pilot study. BMC Endocrine Disorders, 19(1), 38. https://doi.org/10.1186/s12902-019-0363-6

Ebrahimi, Fahim, Wolffenbuttel, Carole, Blum, Claudine A., Baumgartner, Christine, Mueller, Beat, Schuetz, Philipp, Meier, Christian, Kraenzlin, Marius, Christ-Crain, Mirjam, & Betz, Matthias Johannes. (2019). Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trials. European Respiratory Journal, 53(2). https://doi.org/10.1183/13993003.00973-2018

Struja T, Eckart A, Kutz A, Neyer P, Kraenzlin M, Mueller B, Meier C, Bernasconi L, & Schuetz P. (2019). Metabolomics and Their Ability to Distinguish Thyroid Disorders: A Retrospective Pilot Study. Hormone and Metabolic Research, 51(4), 256–260. https://doi.org/10.1055/a-0850-9691

Suhm, Norbert, Müller, Sebastian, Kungler, Evelyn, Meier, Christian, Kränzlin, Marius, Kränzlin, Claude, Jakob, Marcel, & Saxer, Franziska. (2019). Der Osteoporosis Care Gap bei Altersfrakturpatienten kann durch osteologische Begleitung entlang des Behandlungspfads minimiert werden! The Osteoporosis Care Gap in Geriatric Fracture Patients can be minimized when Osteology is integrated into the Treatment Pathway! Osteologie, 28(2), 140–144. https://doi.org/10.1055/a-0797-4638

Vavanikunnel, Janina, Charlier, Sarah, Becker, Claudia, Schneider, Cornelia, Jick, Susan S., Meier, Christoph R., & Meier, Christian. (2019). Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study. The Journal of Clinical Endocrinology and Metabolism, 104(5), 1645–1654. https://doi.org/10.1210/jc.2018-01879

Struja T, Eckart A, Kutz A, Huber A, Neyer P, Kraenzlin M, Mueller B, Meier C, Bernasconi L, & Schuetz P. (2018). Metabolomics for prediction of relapse in Graves’ disease: Observational pilot study. Frontiers in Endocrinology, 9(OCT), 623. https://doi.org/10.3389/fendo.2018.00623

Refardt, Julie, Farina, Patricia, Hoesli, Irene, & Meier, Christian. (2018). Hypercalcemic crisis in third trimenon: evaluating the optimal treatment strategy. Gynecological Endocrinology, 34(10), 833–836. https://doi.org/10.1080/09513590.2018.1462314

Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, Meier C, Eser P, & von der Weid NX. (2017). A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): Study design of a randomized controlled trial [NCT02730767]. BMC Cancer, 17(1), 822. https://doi.org/10.1186/s12885-017-3801-8

Struja T, Kutz A, Fischli S, Meier C, Mueller B, Recher M, & Schuetz P. (2017). Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease. BMC Medicine, 15(1), 174. https://doi.org/10.1186/s12916-017-0939-9

Meier C, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, & Ferrari S. (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO). Swiss Medical Weekly, 147, w14484. https://doi.org/10.4414/smw.2017.14484

Gotthardt, Frank, Huber, Christine, Thierfelder, Clara, Grize, Leticia, Kraenzlin, Marius, Scheidegger, Claude, & Meier, Christian. (2017). Bone mineral density and its determinants in men with opioid dependence. Journal of Bone and Mineral Metabolism, 35(1), 99–107. https://doi.org/10.1007/s00774-015-0732-9

Struja, Tristan, Kaeslin, Marina, Boesiger, Fabienne, Jutzi, Rebecca, Imahorn, Noemi, Kutz, Alexander, Bernasconi, Luca, Mundwiler, Esther, Mueller, Beat, Christ-Crain, Mirjam, Meienberg, Fabian, Ebrahimi, Fahim, Henzen, Christoph, Fischli, Stefan, Kraenzlin, Marius, Meier, Christian, & Schuetz, Philipp. (2017). External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients. European Journal of Endocrinology, 176(4), 413–419. https://doi.org/10.1530/eje-16-0986

Struja, Tristan Mirko, Kutz, Alexander, Fischli, Stefan, Meier, Christian J., Müller, Beat, & Schütz, Philipp. (2017). Personalised immunomodulating treatments for Graves’ disease: fact or fiction? Swiss Medical Weekly, 147, w14476. https://doi.org/10.4414/smw.2017.14476

Egger A, Kraenzlin ME, & Meier C. (2016). Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health. Current Osteoporosis Reports, 14(6), 345–350. https://doi.org/10.1007/s11914-016-0337-9

Oranges CM, Meier C, & Schaefer DJ. (2016). Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients (Patent No. 3). Plastic and Reconstructive Surgery, 138(3), Article 3. https://doi.org/10.1097/prs.0000000000002506

Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, Meier, Christian, Jick, Susan S., & Meier, Christoph R. (2016). New Use of Statins and the Risk of Achilles or Biceps Tendon Rupture: A Propensity-Score Matched Cohort Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 25, 563.

Egger, A., Kraenzlin, M., & Meier, C. (2016). Osteoporosis and type 2 diabetes. DIABETOLOGE, 12, 254–260. https://doi.org/10.1007/s11428-016-0098-1

Trombetti A, Christ E.R., Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Meier C. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms. Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3

Meier C, Schwartz AV, Egger A, & Lecka-Czernik B. (2016). Effects of diabetes drugs on the skeleton. Bone, 82, 93–100. https://doi.org/10.1016/j.bone.2015.04.026

Spoendlin, Julia, Layton, J. Bradley, Mundkur, Mallika, Meier, Christian, Meier, Christian, Jick, Susan S., & Meier, Christoph R. (2016). The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Safety, 39(12), 1229–1237. https://doi.org/10.1007/s40264-016-0462-5

Spoendlin, Julia, Meier, Christian, Meier, Christian, Jick, Susan S., & Meier, Christoph R. (2016). Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study. Journal of Diabetes and Its Complications, 30(5), 9–903. https://doi.org/10.1016/j.jdiacomp.2016.02.017

Suhm N, Meier C, Kraenzlin M, Kungler E, Savic B, Mueller S, Jakob M, & Rikli D. (2016). [FLS - three letters alter secondary fracture prevention]. Der Unfallchirurg, 119(1), 7–12. https://doi.org/10.1007/s00113-015-0122-8

Theiler, R., Freystaetter, G., Platz, A., Meier, C., & Mellinghoff, H. -U. (2016). Capture the fracture by SMS. Osteologie, 25(4), 283–286. https://doi.org/10.1055/s-0037-1619024

Meier C. (2015). Benefits and place of calcimimetics in the management of primary hyperparathyroidism. Annales d’Endocrinologie, 76(2), 163–164. https://doi.org/10.1016/j.ando.2015.03.019

Spoendlin, Julia, Meier, Christian, Jick, Susan S, & Meier, Christoph R. (2015). Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study. Annals of Medicine, 47(6), 8–492. https://doi.org/10.3109/07853890.2015.1074272

Meier, Christian, Lamy, Olivier, Krieg, Marc-Antoine, Mellinghoff, Hans-Ulrich, Felder, Markus, Ferrari, Serge, & Rizzoli, Rene. (2014). The role of teriparatide in sequential and combination therapy of osteoporosis. Swiss Medical Weekly, 144. https://doi.org/10.4414/smw.2014.13952

Stute P, Birkhäuser M, von Wolff M, & Meier C. (2014). Gynaecologists’ awareness of bone healthcare in Switzerland. Swiss Medical Weekly, 144, w13931. https://doi.org/10.4414/smw.2014.13931

Kreutle, V., Blum, C., Meier, C., Past, M., Muller, B., Schutz, P., & Borm, K. (2014). Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature. Swiss Medical Weekly, 144, w13979. https://doi.org/10.4414/smw.2014.13979

Meier, C, Meier, C, Kraenzlin, C, Friederich, N F, Wischer, T, Grize, L, Meier, C R, & Kraenzlin, M E. (2014). Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial. Osteoporosis International, 25(1), 66–359. https://doi.org/10.1007/s00198-013-2581-5

Nigro N, Christ-Crain M., & Meier C. (2014). Testosterone replacement therapy in the aging male - Risks and benefits Hormonersatzbehandlung in der andropause - Nutzen und risiken. Therapeutische Umschau, 71(4), 229–237. https://doi.org/10.1024/0040-5930/a000506

Henzen C, Kraenzlin M, & Meier C. (2013). [Laboratory investigation of endocrine function - interpretation of results and pitfalls]. Therapeutische Umschau. Revue therapeutique, 70(8), 9–481. https://doi.org/10.1024/0040-5930/a000435

Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, & Meier C. (2013). Intravenous bisphosphonates for postmenopausal osteoporosis: Safety profiles of zoledronic acid and ibandronate in clinical practice. Clinical Drug Investigation, 33(2), 117–122. https://doi.org/10.1007/s40261-012-0041-1

Meier C, & Kraenzlin ME. (2012). [Osteoporosis: evaluation, diagnosis and monitoring]. Therapeutische Umschau. Revue Therapeutique, 69(3), 52–145. https://doi.org/10.1024/0040-5930/a000267

Bodmer, Michael, Becker, Claudia, Meier, Christian, Meier, Christian, Jick, Susan S., & Meier, Christoph R. (2012). Use of antidiabetic agents and the risk of pancreatic cancer : a case-control analysis. The American Journal of Gastroenterology, 107(4), 620–626. https://doi.org/10.1038/ajg.2011.483

Bodmer, Michael, Becker, Claudia, Meier, Christian, Meier, Christian, Jick, Susan S., & Meier, Christoph R. (2012). Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiology Biomarkers & Prevention, 21(2), 280–286. https://doi.org/10.1158/1055-9965.epi-11-0992-t

Suter-Widmer I, Kraenzlin ME, & Meier C. (2011). [Primary hyperparathyroidism]. Therapeutische Umschau. Revue Therapeutique, 68(6), 6–321. https://doi.org/10.1024/0040-5930/a000172

Bodmer, Michael, Becker, Claudia, Meier, Christian, Meier, Christian, Jick, Susan S., & Meier, Christoph R. (2011). Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecologic Oncology, 123(2), 200–204. https://doi.org/10.1016/j.ygyno.2011.06.038

Kraenzlin, Marius E, & Meier, Christian. (2011). Parathyroid hormone analogues in the treatment of osteoporosis. Nature Reviews. Endocrinology, 7(11), 56–647. https://doi.org/10.1038/nrendo.2011.108

Meier, Christian, & Kränzlin, Marius E. (2011). Calcium supplementation, osteoporosis and cardiovascular disease. Swiss Medical Weekly, 141, w13260. https://doi.org/10.4414/smw.2011.13260

Meier C, & Kraenzlin ME. (2011). Antiepileptics and bone health. Therapeutic Advances in Musculoskeletal Disease, 3(5), 235–243. https://doi.org/10.1177/1759720x11410769

Suter-Widmer, Isabelle, Kraenzlin, Marius E, & Meier, Christian. (2011). Primärer Hyperparathyreoidismus. Therapeutische Umschau, 68(6), 6–321. https://doi.org/10.1024/0040-5930/a000172

Bodmer, Michael, Meier, Christian, Meier, Christian, Kraenzlin, Marius E., & Meier, Christoph R. (2010). Proton pump inhibitors and fracture risk: true effect or residual confounding? Drug Safety, 33(10), 52–843. https://doi.org/10.2165/11536780-000000000-00000

Bodmer, Michael, Meier, Christian, Meier, Christian, Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2010). Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care, 33(6), 8–1304. https://doi.org/10.2337/dc09-1791

Keel, Christina, Kraenzlin, Marius E., Kraenzlin, Claude A., Müller, Beat, & Meier, Christian. (2010). Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice. Journal of Bone and Mineral Metabolism, 28(1), 68–76. https://doi.org/10.1007/s00774-009-0101-7

Kraenzlin, Marius E, Graf, Christian, Meier, Christian, Kraenzlin, Claude, & Friedrich, Niklaus F. (2010). Possible beneficial effect of bisphosphonates in osteonecrosis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy, 18(12), 44–1638. https://doi.org/10.1007/s00167-010-1106-4

Meier, Christian, Brauchli, Yolanda B, Jick, Susan S, Kraenzlin, Marius E, & Meier, Christoph R. (2010). Use of depot medroxyprogesterone acetate and fracture risk. Journal of clinical endocrinology and metabolism, 95(11), 16–4909. https://doi.org/10.1210/jc.2010-0032

Walter, Martin A., Meier, Christian, Radimerski, Tanja, Iten, Fabienne, Kränzlin, Marius, Müller-Brand, Jan, de Groot, Jan Willem B., Kema, Ido P., Links, Thera P., & Müller, Beat. (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer, 116(1), 31–40. https://doi.org/10.1002/cncr.24738

Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, & Rizzoli R. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Medical Weekly, 139(27-28), 400–404. https://doi.org/10.4414/smw.2009.12635

Meier C, Meier C, Bodmer M, Meier CR, & Kraenzlin ME. (2009). [Thiazolidinediones and skeletal health]. Revue medicale suisse, 5(207), 1309–1310, 1312–1313.

Bodmer, Michael, Meier, Christian, Meier, Christian, Kraenzlin, Marius E, & Meier, Christoph R. (2009). Risk of fractures with glitazones : a critical review of the evidence to date [Review of Risk of fractures with glitazones : a critical review of the evidence to date]. Drug Safety, 32, Article 7. https://doi.org/10.2165/00002018-200932070-00001

De Geyter, C., Steimann, S., Müller, B., Kränzlin, M. E., & Meier, C. (2009). Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. Thyroid, 19(1), 9–53. https://doi.org/10.1089/thy.2007.0355

Meier, Christian. (2009). [Osteoporosis: diagnostic assessment]. Schweizerische Rundschau Für Medizin Praxis = Revue Suisse de Médecine PRAXIS, 98(20), 7–1141. https://doi.org/10.1024/1661-8157.98.20.1141

Meier, Christian, Seibel, Markus J, & Kraenzlin, Marius E. (2009). Use of bone turnover markers in the real world: are we there yet? Journal of Bone and Mineral Research : JBMR : The Official Journal of the American Society for Bone and Mineral Research, 24(3), 8–386. https://doi.org/10.1359/jbmr.090104

Richert, Laura, Trombetti, Andrea, Herrmann, François R, Triponez, Frédéric, Meier, Christian, Robert, John H, & Rizzoli, René. (2009). Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 139(27-28), 4–400. https://doi.org/smw-12635

Kränzlin,ME, & Meier,C. (2008). Prävention der Osteoporose. Ars Medici, 13(5), 581–585.

Meier,C, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose. Leading Opinons Gynäkologie, 1(4), 14–17.

Bodmer, Michael, Meier, Christian, Krähenbühl, Stephan, Jick, Susan S, & Meier, Christoph R. (2008). Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis. Diabetes Care, 31(11), 91–2086. https://doi.org/10.2337/dc08-1171

Kraenzlin, Marius E., Kraenzlin, Claude A., Meier, Christian, Giunta, Cecilia, & Steinmann, Beat. (2008). Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases. Clinical Chemistry, 54(9), 53–1546. https://doi.org/10.1373/clinchem.2008.105262

Kränzlin, Marius E., & Meier, Christian. (2008). Prävention der Osteoporose. Ars Edici Dossier, Schweizer Zeitschrift Für Hausarztmedizin, 12, 27–31. https://www.rosenfluh.ch/media/arsmedici-dossier/2008/12/Praevention-der-Osteoporose.pdf

Meier, Christian, Kraenzlin, Marius E., Bodmer, Michael, Jick, Susan S., Jick, Hershel, & Meier, Christoph R. (2008). Use of thiazolidinediones and fracture risk. Archives of Internal Medicine, 168(8), 820–825. https://doi.org/10.1001/archinte.168.8.820

Meier, Christian, Nguyen, Tuan V, Handelsman, David J, Schindler, Christian, Kushnir, Mark M, Rockwood, Alan L, Meikle, A Wayne, Center, Jacqueline R, Eisman, John A, & Seibel, Markus J. (2008). Endogenous sex hormones and incident fracture risk in older men : the Dubbo Osteoporosis Epidemiology Study. Archives of Internal Medicine, 168(1), 47–54. https://doi.org/10.1001/archinternmed.2007.2

Meier,C, & Kränzlin,ME. (2008). Aromatasehemmer und Osteoporose. Leading Opinons. Gynäkologie, 1, 14–17.

Meier,C, & Kränzlin,ME. (2008). Therapieoptionen bei postmenopausaler Osteoporose. Gynäkologie, 1, 13–20.

Kraenzlin ME, & Meier C. (2007). Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women? Commentary. Nature Clinical Practice Endocrinology and Metabolism, 3(10), 686–687. https://doi.org/10.1038/ncpendmet0618

Nguyen TV, Meier C, Center JR, Eisman JA, & Seibel MJ. (2007). Bone turnover in elderly men: Relationships to change in bone mineral density. BMC Musculoskeletal Disorders, 8, 13. https://doi.org/10.1186/1471-2474-8-13

Liu PY, Beilin J, Meier C, Nguyen TV, Center JR, Leedman PJ, Seibel MJ, Eisman JA, & Handelsman DJ. (2007). Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts. Journal of Clinical Endocrinology and Metabolism, 92(9), 3599–3603. https://doi.org/10.1210/jc.2007-0862

Meier C, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, & Seibel MJ. (2006). Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget’s disease. Clinical Laboratory, 52(1-2), 1–10.

Kraenzlin ME, & Meier C. (2006). Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer. Expert Opinion on Biological Therapy, 6(2), 167–176. https://doi.org/10.1517/14712598.6.2.167

Meier,C, & Kraenzlin,M.E. (2005). Diagnose und Therapie der postmenopausalen Osteoporose. Z Allgemeinmed, 81(14), 289–302.

Meier C, Liu PY, Handelsman DJ, & Seibel MJ. (2005). Endocrine regulation of bone turnover in men. Clinical Endocrinology, 63(6), 603–616. https://doi.org/10.1111/j.1365-2265.2005.02333.x

Meier C, Christ-Crain M, Christoffel-Courtin C, Staub JJ, & Müller B. (2005). Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: Reassessment of the hCG stimulation test. Clinical Laboratory, 51(9-10), 509–515.

Christ-Crain M, Morgenthaler NG, Meier C, Müller C, Nussbaumer C, Bergmann A, Staub JJ, & Müller B. (2005). Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Medical Weekly, 135(37-38), 549–554. https://doi.org/10.4414/smw.2005.11119

Meier C, Nguyen TV, Center JR, Seibel MJ, & Eisman JA. (2005). Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study. Journal of Bone and Mineral Research, 20(4), 579–587. https://doi.org/10.1359/jbmr.041207

Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Meier C, Hooper MJ, & Ralston SH. (2005). Ubiquitin-associated domain mutations of SQSTM1 in Paget’s disease of bone: Evidence for a founder effect in patients of British descent. Journal of Bone and Mineral Research, 20(2), 227–231. https://doi.org/10.1359/jbmr.041106

Christ-Crain, M., Meier, C., Huber, P. R., Zimmerli, L., & Müller, B. (2005). Value of gonadotropin-releasing hormone testing in the differential diagnosis of androgen deficiency in elderly men. Journal of Clinical Endocrinology and Metabolism, 90(3), 6–1280. https://doi.org/10.1210/jc.2004-0850

Christ-Crain,M, Meier,C, Huber,P.R., Keller,U, Staub,J.J., & Müller,B. (2004). Effect of L-Thyroxine Replacement Therapy on Skeletal and Cardiac Function in Subclinical Hypothyroidism. The Endocrinologist, 14(1616), 6–161.

Meier C, Woitge HW, Witte K, Lemmer B, & Seibel MJ. (2004). Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: A randomized controlled open-label prospective trial. Journal of Bone and Mineral Research, 19(8), 1221–1230. https://doi.org/10.1359/jbmr.040511